A2780
|
IC50 |
|
Antiproliferative activity against cisplatin-sensitive human A2780 cells measured after 96 hrs by MTT assay
Antiproliferative activity against cisplatin-sensitive human A2780 cells measured after 96 hrs by MTT assay
|
[PMID: 31008605]
|
A549
|
IC50 |
|
Cytotoxicity against human A549 cells assessed as reduction in cell viability using compound addition to cell culture cells in log phase of growth and incubated for 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell viability using compound addition to cell culture cells in log phase of growth and incubated for 48 hrs by MTT assay
|
[PMID: 28923386]
|
A549
|
IC50 |
|
Cytotoxicity against human A549 cells assessed as reduction in cell viability using compound addition to cell culture cells in lag phase of growth and incubated for 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell viability using compound addition to cell culture cells in lag phase of growth and incubated for 48 hrs by MTT assay
|
[PMID: 28923386]
|
ACHN
|
IC50 |
|
Sensitization of TRAIL-induced apoptosis in human ACHN cells assessed as reduction in cell viability preincubated for 2 hrs followed by addition of TRAIL measured after 18 hrs by MTS assay
Sensitization of TRAIL-induced apoptosis in human ACHN cells assessed as reduction in cell viability preincubated for 2 hrs followed by addition of TRAIL measured after 18 hrs by MTS assay
|
[PMID: 28257574]
|
ARPE-19
|
IC50 |
|
Cytotoxicity against human ARPE19 cells measured after 96 hrs by MTT assay
Cytotoxicity against human ARPE19 cells measured after 96 hrs by MTT assay
|
[PMID: 31008605]
|
BXPC-3
|
IC50 |
|
Antiproliferative activity against human BxPC3 cells after 48 hrs by MTS assay
Antiproliferative activity against human BxPC3 cells after 48 hrs by MTS assay
|
[PMID: 31663736]
|
HCT-116
|
IC50 |
|
Anticancer activity against human HCT-116 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay
Anticancer activity against human HCT-116 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay
|
[PMID: 33445154]
|
HEK-293T
|
IC50 |
|
Cytotoxicity against human 293T cells assessed as reduction in cell viability after 72 hrs by resazurin dye based Alamar blue assay
Cytotoxicity against human 293T cells assessed as reduction in cell viability after 72 hrs by resazurin dye based Alamar blue assay
|
[PMID: 29537263]
|
HeLa
|
IC50 |
|
Cytotoxicity against human HeLa cells assessed as reduction in cell viability using compound addition to cell culture cells in lag phase of growth and incubated for 48 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as reduction in cell viability using compound addition to cell culture cells in lag phase of growth and incubated for 48 hrs by MTT assay
|
[PMID: 28923386]
|
HeLa
|
IC50 |
|
Cytotoxicity against human HeLa cells assessed as reduction in cell viability using compound addition to cell culture cells in log phase of growth and incubated for 48 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as reduction in cell viability using compound addition to cell culture cells in log phase of growth and incubated for 48 hrs by MTT assay
|
[PMID: 28923386]
|
HFF
|
IC50 |
|
Cytotoxicity against human HFF cells after 72 hrs by resazurin-based colorimetric assay
Cytotoxicity against human HFF cells after 72 hrs by resazurin-based colorimetric assay
|
[PMID: 27071003]
|
LNCaP
|
IC50 |
|
Cytotoxicity against human LNCAP cells after 72 hrs by resazurin-based colorimetric assay
Cytotoxicity against human LNCAP cells after 72 hrs by resazurin-based colorimetric assay
|
[PMID: 27071003]
|
MCF7
|
IC50 |
|
Cytotoxicity against human MCF7 cells after 72 hrs by resazurin-based colorimetric assay
Cytotoxicity against human MCF7 cells after 72 hrs by resazurin-based colorimetric assay
|
[PMID: 27071003]
|
MCF7
|
IC50 |
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability using compound addition to cell culture cells in log phase of growth and incubated for 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability using compound addition to cell culture cells in log phase of growth and incubated for 48 hrs by MTT assay
|
[PMID: 28923386]
|
MCF7
|
IC50 |
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability using compound addition to cell culture cells in lag phase of growth and incubated for 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability using compound addition to cell culture cells in lag phase of growth and incubated for 48 hrs by MTT assay
|
[PMID: 28923386]
|
MIA PaCa-2
|
IC50 |
|
Antiproliferative activity against human MIAPaCa2 cells after 48 hrs by MTS assay
Antiproliferative activity against human MIAPaCa2 cells after 48 hrs by MTS assay
|
[PMID: 31663736]
|
MM1.S
|
IC50 |
|
Antiproliferative activity against human MM1.S cells assessed as reduction in cell viability incubated for 72 hrs by XTT assay
Antiproliferative activity against human MM1.S cells assessed as reduction in cell viability incubated for 72 hrs by XTT assay
|
[PMID: 34445874]
|
Multiple myeloma cancer stem cell
|
IC50 |
|
Antiproliferative activity against human multiple myeloma cancer stem cells after 72 hrs by MTT assay
Antiproliferative activity against human multiple myeloma cancer stem cells after 72 hrs by MTT assay
|
[PMID: 30108696]
|
NCI-H460
|
IC50 |
|
Cytotoxicity against human NCI-H460 cells after 72 hrs by resazurin-based colorimetric assay
Cytotoxicity against human NCI-H460 cells after 72 hrs by resazurin-based colorimetric assay
|
[PMID: 27071003]
|
PANC-1
|
IC50 |
|
Antiproliferative activity against human PANC1 cells after 48 hrs by MTS assay
Antiproliferative activity against human PANC1 cells after 48 hrs by MTS assay
|
[PMID: 31663736]
|
PC-3M
|
IC50 |
|
Cytotoxicity against human PC3M cells after 72 hrs by resazurin-based colorimetric assay
Cytotoxicity against human PC3M cells after 72 hrs by resazurin-based colorimetric assay
|
[PMID: 27071003]
|
RPMI-8226
|
IC50 |
|
Antiproliferative activity against human RPMI-8226 cells cultured as 3D-spheroids assessed as reduction in cell viability after 48 hrs by Celltiter-Glo assay
Antiproliferative activity against human RPMI-8226 cells cultured as 3D-spheroids assessed as reduction in cell viability after 48 hrs by Celltiter-Glo assay
|
[PMID: 34445874]
|
RPMI-8226
|
IC50 |
|
Antiproliferative activity against human RPMI 8226 cells assessed as reduction in cell viability incubated for 72 hrs by XTT assay
Antiproliferative activity against human RPMI 8226 cells assessed as reduction in cell viability incubated for 72 hrs by XTT assay
|
[PMID: 34445874]
|
SF-268
|
IC50 |
|
Cytotoxicity against human SF268 cells after 72 hrs by resazurin-based colorimetric assay
Cytotoxicity against human SF268 cells after 72 hrs by resazurin-based colorimetric assay
|
[PMID: 27071003]
|
SW480
|
IC50 |
|
Anticancer activity against human SW480 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay
Anticancer activity against human SW480 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay
|
[PMID: 33445154]
|
Vero
|
IC50 |
|
Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability using compound addition to cell culture cells in lag phase of growth and incubated for 48 hrs by MTT assay
Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability using compound addition to cell culture cells in lag phase of growth and incubated for 48 hrs by MTT assay
|
[PMID: 28923386]
|
Vero
|
IC50 |
|
Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability using compound addition to cell culture cells in log phase of growth and incubated for 48 hrs by MTT assay
Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability using compound addition to cell culture cells in log phase of growth and incubated for 48 hrs by MTT assay
|
[PMID: 28923386]
|